團隊
ホーム >> 専門分野 >> 商標権紛争処理 >> Roger Chang
張哲倫 Roger Chang

Roger Chang Roger Chang

パートナー

聯絡方式

Roger has extensive experience in intellectual property infringement litigation, licensing, strategy planning, and antitrust and competition regulation advice. Roger is active in trademark, copyright, and patent litigation for various industries. In 2019, represented by Roger, AVIS was awarded 3 million USD by the Intellectual Property Court in a trademark infringement case. In 2019, Entegris was awarded 32 million USD in a patent infringement case. In 2017, Philips was awarded 35 million USD in a patent infringement suit. In 2013, Philips was awarded 10 million USD in a patent case. In 2011, ESI, a NASDAQ-listed company based in Oregon, was awarded 24 million USD in a patent infringement suit. In 2010, another case represented by Roger, Philips was awarded 68 million USD for patent infringement damages. In 2009, the Intellectual Property Court awarded Philips 75 million USD as royalty of patent licensing. In 2007, in a landmark case that he participated in, the Taipei District Court awarded Celanese 68 million USD as damages for patent infringement. Known for his in-depth understanding of complex matters involving intellectual property and ability to provide innovative and constructive solutions, Roger is regularly invited to speak at seminars and workshops and publish articles on intellectual property and antitrust laws. Roger has also assisted Taiwanese government agencies in amendments to intellectual property and competition-related laws and regulations

學歷

專業領域

Intellectual Property Litigation and Licensing; Antitrust and Competition

經歷

Secretary General to the Taiwan Patent Attorneys Association
Adjunct assistant professor in Intellectual Property, National Taipei University Law School
Arbitrator, the Arbitration Association of Republic of China

資格

admitted 1997, Attorney; 1997, Patent Agent; 2009, Patent Attorney, R.O.C. (Taiwan)
Taipei Bar Association
Taoyuan Bar Association.
Hsinchu Bar Association

語言

2023年 Court rules in favour of pharmaceutical companies that market category two new drugs
ILO IP Newsletter (20230424)
2023年 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY
2023年 2022年最高法院及最高行政法院關鍵專利判決
月旦律評12期
2022年 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY
2021年 專利貢獻度對損害賠償界定之影響─兼評最高法院106年度台上字第2467號判決
月旦裁判時報110期
2021年 台湾初のパテントリンケージ訴訟判決(MSD v. 中化製薬)-パテントリンケージ運用への啓発及び影響
LEE & LI Bulletin - June 2021

More


2023年 2023年商标相关国际规范及法规班:公平交易法与商标之规范|讲师
智慧财产培训学院(TIPA)
2023年 台商因应欧洲统一专利系统应有之策略思考—IP申请及维权|主持人
理律法律事務所
回上一頁